Kenichi Taguchi - Concepedia

Author

Kenichi Taguchi

Also Known As

H Saeki, Hidetaka Yamamoto, K I Taguchi, K Taguchi, K. Taguchi, K., Taguchi, K.-i. Taguchi, KENICHI TAGUCHI, KEN‐ICHI TAGUCHI, Ken-Ichi Taguchi

273

Publications

Citations

H-Index

116

Concepts

All Affiliations

Kyushu University National Hospital Organization Kyushu Cancer Center Hamanomachi Hospital

About

Kenichi Taguchi is an author at Kyushu University specializing in medicine, pathology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	60	2.9K
2	Health Sciences	11	12	627
3	Engineering	4	4	412
4	Natural Sciences	1	1	13
5	Public Health	1	1	31

Kenichi Taguchi

126

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
An injectable, in situ enzymatically gellable, gelatin derivative for drug delivery and tissue engineering Shinji Sakai, Keisuke Hirose, Kenichi Taguchi, Biomaterials Tissue EngineeringRegenerative MedicineBiopolymer GelBiomanufacturingEngineering	2009	349
<i><scp>ALK</scp></i>,<i><scp>ROS</scp>1</i> and <i><scp>NTRK</scp>3</i> gene rearrangements in inflammatory myofibroblastic tumours Hidetaka Yamamoto, Akihiko Yoshida, Kenichi Taguchi, Histopathology	2015	205
Transcriptional repressor snail and progression of human hepatocellular carcinoma. K Sugimachi, Shinji Tanaka, Toshifumi Kameyama, PubMed	2003	172
Sequential Hemodynamic Change in Hepatocellular Carcinoma and Dysplastic Nodules Tsuyoshi Tajima, Hiroshi Honda, Kenichi Taguchi, American Journal of Roentgenology	2002	153
Proposal of Progression Model for Intrahepatic Cholangiocarcinoma: Clinicopathologic Differences Between Hilar Type and Peripheral Type Shinichi Aishima, Yousuke Kuroda, Yunosuke Nishihara, The American Journal of Surgical Pathology Surgical OncologyGastroenterologyPathologyPrimary Biliary CirrhosisPreserved Architecture	2007	151
The association of death-associated protein kinase hypermethylation with early recurrence in superficial bladder cancers. Yasuhiro Tada, Morimasa Wada, Kenichi Taguchi, PubMed PathologyCell DeathCancer BiologyEpigeneticsTumor Biology	2002	144
A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L Fumihiko Hirai, Takeharu Yamanaka, Kenichi Taguchi, Annals of Oncology Advanced Thymic CarcinomaMedicinePathologyImmune Checkpoint InhibitorMolecular Oncology	2014	128
A phase II study of eribulin in Japanese patients with heavily pretreated metastatic breast cancer K. Aogi, Hiroji Iwata, Norikazu Masuda, Annals of Oncology Metastatic Breast CancerBreast OncologyMedicinePathologyPhase Ii Study	2011	122
Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone Hidetaka Yamamoto, Takeshi Iwasaki, Yuichi Yamada, Human Pathology Tumor BiologyG34v Mutant-specific AntibodiesDiagnostic UtilityHistone H3.3 G34wHistopathology	2017	120
YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma Hirofumi Omori, Miki Nishio, Muneyuki Masuda, Science Advances	2020	115

Page 1